These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 7025628)

  • 1. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I; Pometta D; Micheli H; Raymond L
    Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of circulating high-density lipoprotein and triglycerides in coronary artery disease: risk and prevention.
    Gordon DJ
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):299-309. PubMed ID: 2192875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of HDL-cholesterol].
    Reuter W; Herrmann W
    Z Gesamte Inn Med; 1981 Jul; 36(14):473-9. PubMed ID: 6944971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid changes as a possible risk factor in preclinical hypothyroidism. Preliminary report].
    Gräni R; Staub JJ; Noelpp B; Stähelin HB; Oberhänslin A
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1906-7. PubMed ID: 6800030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins, cardiovascular disease, and death. The Framingham study.
    Gordon T; Kannel WB; Castelli WP; Dawber TR
    Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 9. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening and therapy control of lipid metabolism disturbances in general practice (author's transl)].
    Assmann G; Schriewer H
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):449-52. PubMed ID: 6769013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between abnormal serum lipid and erectile dysfunction].
    Rao K; Du GH; Yang WM
    Zhonghua Nan Ke Xue; 2005 Feb; 11(2):112-5. PubMed ID: 15755029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
    Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HDL-cholesterol and family incidence of coronary disease in the Genevan population].
    Suenram A; Pometta D; von der Weid N
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1926-8. PubMed ID: 6665538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of lipid disorders to coronary heart disease.
    Glueck CJ
    Am J Med; 1983 May; 74(5A):10-4. PubMed ID: 6846376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
    Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Production on the serum lipid and lipoprotein level in ischemic heart disease].
    Orbetsov M; Orbetsova V; Todorova M; Mikhaĭlova M; Atanasova M
    Vutr Boles; 1977; 16(6):16-22. PubMed ID: 203118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting improvements in lipid values following cardiac rehabilitation and exercise training.
    Lavie CJ; Milani RV
    Arch Intern Med; 1993 Apr; 153(8):982-8. PubMed ID: 8481069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.